CARLSBAD, Calif., May 20, 2022 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces that Qualigen Therapeutics Management will present a corporate overview during the H.C. Wainwright Global Investment Conference.… Read More »Qualigen Therapeutics to Present at the H.C. Wainwright Global Investment Conference
The post Qualigen Therapeutics to Present at the H.C. Wainwright Global Investment Conference appeared on Stocks News Feed.